Treating Endometriosis: Pill of Dienogest alone vs. Pill of Dienogest with Hormonal Intrauterine Device - a randomized clinical trial

Phase 3

• Conditions: Endometriosis; C12.050.351.500

• Registration Number: RBR-68j3f26
• Lead Sponsor: niversidade Estadual de Campinas

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-07-16
• Last Update Posted: 22 July 2024
• Study Completion: 2026-12-20

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

Women aged 18 to 45 years. Diagnosis of endometriosis by specific imaging examination ultrasound, magnetic resonance imaging (MRI). Present at study entry with complaints of pelvic pain and/or deep dyspareunia. Agree to the use of dienogest or levonorgestrel intrauterine device (LNG IUD). No contraindications to the use of levonorgestrel intrauterine device (LNG IUD). No desire for pregnancy during the one-year study period

Exclusion Criteria

Asymptomatic women. Women who have not initiated sexual activity. Women with psychiatric or neurological disorders that compromise the ability to respond to the questionnaires developed such as schizophrenia, neurodegenerative disorders, severe depression. Women undergoing treatment for chronic systemic diseases that lead to painful symptoms fibromyalgia, interstitial cystitis, neuropathic pain. History of abdominal surgery hysterectomy, colectomy, exploratory laparotomy, complicated appendectomy

Study & Design

• Study Type: Intervention
• Study Design: Not specified